- Current report filing (8-K)
February 10 2011 - 1:05PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): February 10, 2011 (February 9,
2011)
CHINA-BIOTICS,
INC.
(Exact
Name of Registrant as Specified in Its Charter)
Delaware
(State or
Other Jurisdiction of Incorporation)
333-110733
|
|
98-0393071
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
No.
26, Orient Global Headquarter
Lane
118, Yonghe Road
Zhabei
District, Shanghai 200072
People’s
Republic of China
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
(86 21) 3639 1922
(Registrant’s
Telephone Number, Including Area Code)
Not Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (
see
General
Instruction A.2. below):
o
|
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
2.02 Results of Operations and Financial
Condition.
On
February 9, 2011, China-Biotics, Inc. announced its unaudited financial results
for the quarter ended December 31, 2010. A copy of the press release
related to such announcement is being furnished as Exhibit 99.1 to this Form
8-K.
The
information in this report is being furnished pursuant to Item 2.02 Results of
Operations and Financial Condition. In accordance with General
Instruction B.2 of Form 8-K, the information in this report shall not be deemed
to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, nor shall it be deemed incorporated by reference in any filing under
the Securities Act of 1934, as amended.
Item
9.01 Financial Statements and
Exhibits.
(d)
Exhibits
Number
|
|
Description
|
|
|
|
Exhibit
99.1
|
|
Press
Release of China-Biotics, Inc. dated February 9,
2011.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
China-Biotics,
Inc.
(Registrant)
|
|
|
|
|
|
|
Date: February
10, 2011
|
By:
|
/s/ Song
Jinan
|
|
|
|
Song
Jinan
Chief
Executive Officer, President,
Treasurer
and Secretary
|
|
China-Biotics, Inc. (MM) (NASDAQ:CHBT)
Historical Stock Chart
From Aug 2024 to Sep 2024
China-Biotics, Inc. (MM) (NASDAQ:CHBT)
Historical Stock Chart
From Sep 2023 to Sep 2024